Tag: CBT > Tilray Cannabis Company

Industry Headlines

Tilray Medical Publishes Pioneering Research on Pharmacokinetics of THC, CBD Formulations

The new study provides insight into the bioavailability of medical cannabis formulations for therapeutic treatment.

June 26, 2025

International

Tilray Medical Receives Italy’s 1st Authorization to Distribute Medical Cannabis Flower

The company received the go-ahead from the Italian Ministry of Health to import and distribute three cannabis flower varieties for therapeutic use.

June 24, 2025

Finance

Tilray Brands Announces Proposed Reverse Stock Split

The global cannabis company also announced a corresponding special stockholders meeting.

April 17, 2025

International

Tilray Medical Introduces Cannabis Edibles in Australia

The division of Tilray Brands is expanding its offerings with Good Supply Pastilles to patients in the country.

April 17, 2025

International

Tilray Medical Introduces High-THC, High-Terpene Genetics to German Market

The company launched Tilray Craft, a brand extension within its medical cannabis portfolio in Germany.

March 11, 2025

Industry Headlines

Tilray Expands Medical Cannabis Portfolio in Germany

The company launched new cannabis extract products and formulations.

February 11, 2025

International

Tilray Brands Enhances Global Cannabis Supply Chain

The company increased its industry-leading capacity to meet global demand, driving growth across Canada and Europe.

February 10, 2025

Industry Headlines

Tilray Brands Launches Charlotte’s Web CBD Gummies in Canada

The CBD Life and Rest gummies are available in Ontario and will soon expand to other provinces.

October 7, 2024

Industry Headlines

Tilray Brands Launching Hemp-Derived Delta-9 THC Drinks in Key Markets Across US

The company’s alternative beverage business unit unveiled a portfolio of mocktails, seltzers and sparking drinks made with hemp extracts.

September 24, 2024

International

Tilray Medical Launches Redecan Cannabis Brand in Australia

The company’s EU-GMP-certified medical cannabis products are now available in Australia with a prescription.

September 18, 2024

Mergers and Acquisitions

Tilray to Acquire 4 Craft Beer Breweries From Molson Coors

The global cannabis company’s beverage-market aspirations just got higher, as it entered into a definitive agreement to buy four more beer companies. This follows several years of beverage-company acquisitions and marks a ‘strategic milestone’ in the company’s growth plan.

August 16, 2024

International

Tilray’s Aphria RX Receives Cannabis Trading License in Germany

The license significantly expands the company’s commercial growth opportunities.

July 29, 2024